Search research articles
Contact Us
Filters
Showing results (401-410 of 434) with videos related to
Page
of 44
Sort By:
Journal of Lipid Research
|
November 3, 2004
Role of CYP27A in cholesterol and bile acid metabolism
Sandrine Dubrac, Steven R Lear, Meena Ananthanarayanan, et al.
Gynecologic Oncology
|
September 16, 2022
HER2 in Uterine Serous Carcinoma: Testing platforms and implications for targeted therapy
Tenley R Klc, Sharon Wu, Annelise M Wilhite, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
July 16, 2016
Chemical Structure and Concentration of Intratumor Catabolites Determine Efficacy of Antibody Drug Conjugates
Donglu Zhang, Shang-Fan Yu, Yong Ma, et al.
Gynecologic Oncology
|
April 30, 2022
Molecular profiles of endometrial cancer tumors among Black patients
Annelise M Wilhite, Yasmine Baca, Joanne Xiu, et al.
Mabs
|
January 12, 2016
Microscale screening of antibody libraries as maytansinoid antibody-drug conjugates
Kalli C Catcott, Molly A McShea, Carl Uli Bialucha, et al.
Molecular Pharmaceutics
|
July 10, 2019
A Case Study Comparing Heterogeneous Lysine- and Site-Specific Cysteine-Conjugated Maytansinoid Antibody-Drug Conjugates (ADCs) Illustrates the Benefits of Lysine Conjugation
Nicholas C Yoder, Chen Bai, Daniel Tavares, et al.
Obstetrics and Gynecology
|
December 2, 2014
Detection of somatic TP53 mutations in tampons of patients with high-grade serous ovarian cancer
Britt K Erickson, Isaac Kinde, Zachary C Dobbin, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
June 21, 2017
UCP1 deficiency causes brown fat respiratory chain depletion and sensitizes mitochondria to calcium overload-induced dysfunction
Lawrence Kazak, Edward T Chouchani, Irina G Stavrovskaya, et al.
Gynecologic Oncology
|
May 1, 2022
A phase II trial of bevacizumab and rucaparib in recurrent carcinoma of the cervix or endometrium
C G Jackson, K N Moore, L Cantrell, et al.
Antimicrobial Agents and Chemotherapy
|
December 3, 1999
Expanded-spectrum nonnucleoside reverse transcriptase inhibitors inhibit clinically relevant mutant variants of human immunodeficiency virus type 1
J W Corbett, S S Ko, J D Rodgers, et al.
Page
of 44
Search research articles
Search
Showing results (401-410 of 434) with videos related to
Sort By:
Page
of 44
Journal of Lipid Research
|
November 3, 2004
Role of CYP27A in cholesterol and bile acid metabolism
Sandrine Dubrac, Steven R Lear, Meena Ananthanarayanan, et al.
Gynecologic Oncology
|
September 16, 2022
HER2 in Uterine Serous Carcinoma: Testing platforms and implications for targeted therapy
Tenley R Klc, Sharon Wu, Annelise M Wilhite, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
July 16, 2016
Chemical Structure and Concentration of Intratumor Catabolites Determine Efficacy of Antibody Drug Conjugates
Donglu Zhang, Shang-Fan Yu, Yong Ma, et al.
Gynecologic Oncology
|
April 30, 2022
Molecular profiles of endometrial cancer tumors among Black patients
Annelise M Wilhite, Yasmine Baca, Joanne Xiu, et al.
Mabs
|
January 12, 2016
Microscale screening of antibody libraries as maytansinoid antibody-drug conjugates
Kalli C Catcott, Molly A McShea, Carl Uli Bialucha, et al.
Molecular Pharmaceutics
|
July 10, 2019
A Case Study Comparing Heterogeneous Lysine- and Site-Specific Cysteine-Conjugated Maytansinoid Antibody-Drug Conjugates (ADCs) Illustrates the Benefits of Lysine Conjugation
Nicholas C Yoder, Chen Bai, Daniel Tavares, et al.
Obstetrics and Gynecology
|
December 2, 2014
Detection of somatic TP53 mutations in tampons of patients with high-grade serous ovarian cancer
Britt K Erickson, Isaac Kinde, Zachary C Dobbin, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
June 21, 2017
UCP1 deficiency causes brown fat respiratory chain depletion and sensitizes mitochondria to calcium overload-induced dysfunction
Lawrence Kazak, Edward T Chouchani, Irina G Stavrovskaya, et al.
Gynecologic Oncology
|
May 1, 2022
A phase II trial of bevacizumab and rucaparib in recurrent carcinoma of the cervix or endometrium
C G Jackson, K N Moore, L Cantrell, et al.
Antimicrobial Agents and Chemotherapy
|
December 3, 1999
Expanded-spectrum nonnucleoside reverse transcriptase inhibitors inhibit clinically relevant mutant variants of human immunodeficiency virus type 1
J W Corbett, S S Ko, J D Rodgers, et al.
Page
of 44